Australia markets open in 9 hours 22 minutes

Getein Biotech, Inc (603387.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
9.04+0.04 (+0.44%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.58B
Enterprise value 4.41B
Trailing P/E 18.08
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.17
Price/book (mrq)1.83
Enterprise value/revenue 3.05
Enterprise value/EBITDA 15.36

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-36.52%
S&P500 52-week change 322.36%
52-week high 314.39
52-week low 37.44
50-day moving average 38.99
200-day moving average 310.67

Share statistics

Avg vol (3-month) 35.04M
Avg vol (10-day) 33.89M
Shares outstanding 5507.15M
Implied shares outstanding 6507.15M
Float 8279.64M
% held by insiders 147.38%
% held by institutions 12.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.4
Forward annual dividend yield 44.42%
Trailing annual dividend rate 30.44
Trailing annual dividend yield 34.89%
5-year average dividend yield 41.85
Payout ratio 480.00%
Dividend date 3N/A
Ex-dividend date 427 Sept 2023
Last split factor 21.4:1
Last split date 308 June 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 17.49%
Operating margin (ttm)18.97%

Management effectiveness

Return on assets (ttm)2.91%
Return on equity (ttm)9.64%

Income statement

Revenue (ttm)1.45B
Revenue per share (ttm)2.85
Quarterly revenue growth (yoy)-26.30%
Gross profit (ttm)N/A
EBITDA 249.37M
Net income avi to common (ttm)252.78M
Diluted EPS (ttm)0.50
Quarterly earnings growth (yoy)-58.50%

Balance sheet

Total cash (mrq)944.73M
Total cash per share (mrq)1.86
Total debt (mrq)769.21M
Total debt/equity (mrq)28.71%
Current ratio (mrq)2.26
Book value per share (mrq)4.95

Cash flow statement

Operating cash flow (ttm)421.58M
Levered free cash flow (ttm)-525.75M